Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,185 | 1,070 | 52.2% |
| Consulting Fee | $22,713 | 15 | 38.0% |
| Honoraria | $3,000 | 1 | 5.0% |
| Travel and Lodging | $2,717 | 19 | 4.5% |
| Education | $141.67 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MAYNE PHARMA INC. | $7,044 | 19 | $0 (2021) |
| PFIZER INC. | $6,679 | 146 | $0 (2024) |
| Allergan Inc. | $6,647 | 23 | $0 (2019) |
| LEO Pharma Inc. | $4,516 | 94 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $4,301 | 85 | $0 (2024) |
| Celgene Corporation | $3,501 | 31 | $0 (2019) |
| Sensus Healthcare, Inc. | $3,000 | 1 | $0 (2017) |
| ABBVIE INC. | $2,773 | 95 | $0 (2024) |
| Promius Pharma LLC | $2,277 | 14 | $0 (2018) |
| Galderma Laboratories, L.P. | $2,204 | 88 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,984 | 156 | Dermavant Sciences, Inc. ($775.59) |
| 2023 | $3,494 | 111 | Dermavant Sciences, Inc. ($581.36) |
| 2022 | $3,902 | 129 | Galderma Laboratories, L.P. ($464.07) |
| 2021 | $3,006 | 111 | Novartis Pharmaceuticals Corporation ($362.43) |
| 2020 | $1,844 | 61 | Novartis Pharmaceuticals Corporation ($512.19) |
| 2019 | $5,746 | 168 | Celgene Corporation ($1,555) |
| 2018 | $8,830 | 160 | LEO Pharma Inc. ($2,934) |
| 2017 | $28,950 | 217 | Mayne Pharma Inc. ($6,950) |
All Payment Transactions
1,113 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Immunology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.97 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $10.37 | General |
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Immunology | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.76 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $4.00 | General |
| 11/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $3.64 | General |
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.21 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.62 | General |
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 567 | 594 | $160,655 | $54,086 |
| 2022 | 6 | 486 | 594 | $157,136 | $60,939 |
| 2021 | 7 | 565 | 657 | $146,353 | $65,914 |
| 2020 | 11 | 502 | 580 | $167,953 | $64,705 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 122 | $30,500 | $11,091 | 36.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 83 | 89 | $27,162 | $10,894 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 99 | 103 | $25,750 | $8,144 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 55 | $18,700 | $6,300 | 33.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Facility | 2023 | 59 | 62 | $19,282 | $5,072 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 27 | $9,180 | $3,207 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $7,920 | $2,408 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,200 | $1,999 | 27.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 36 | 36 | $4,257 | $1,591 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,598 | $1,369 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 27 | 28 | $3,444 | $1,220 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $2,662 | $791.89 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 228 | $57,000 | $22,203 | 39.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 117 | 151 | $45,300 | $18,857 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 74 | $25,160 | $9,073 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $12,600 | $4,074 | 32.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $9,438 | $3,466 | 36.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 62 | 67 | $7,638 | $3,266 | 42.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 262 | $50,555 | $25,762 | 51.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 139 | 174 | $52,200 | $19,929 | 38.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 58 | 66 | $17,160 | $9,253 | 53.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $9,480 | $3,432 | 36.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 69 | 72 | $8,208 | $3,420 | 41.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $6,806 | $3,104 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $1,944 | $1,015 | 52.2% |
About Dr. May Chow, M.D
Dr. May Chow, M.D is a Dermatology healthcare provider based in Olympia Fields, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518918879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. May Chow, M.D has received a total of $59,756 in payments from pharmaceutical and medical device companies, with $3,984 received in 2024. These payments were reported across 1,113 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($31,185).
As a Medicare-enrolled provider, Chow has provided services to 2,120 Medicare beneficiaries, totaling 2,425 services with total Medicare billing of $245,644. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Olympia Fields, IL
- Active Since 05/12/2006
- Last Updated 03/22/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518918879
Products in Payments
- DORYX (Drug) $7,027
- EUCRISA (Drug) $6,429
- Otezla (Drug) $3,794
- COSENTYX (Biological) $3,403
- PICATO (Drug) $2,807
- RHOFADE (Drug) $1,725
- Sernivo Spray 120ml (Drug) $1,664
- DUPIXENT (Biological) $1,612
- Humira (Biological) $1,560
- VTAMA (Drug) $1,483
- Neo-Synalar Cream (Drug) $1,009
- ENSTILAR (Drug) $939.99
- SILIQ (Drug) $787.08
- Sotyktu (Drug) $778.25
- Cimzia (Drug) $757.68
- TALTZ (Drug) $656.61
- CLODERM (Drug) $561.80
- COSENTYX (Drug) $561.46
- Impoyz (Drug) $524.33
- OPZELURA (Drug) $488.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.